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III. ABSTRACT OF ACCOMPLISHMENTS
During the total period of this contract and its extensions, a
logical progression of events--through preliminary experiments then design
and construction of a low pressure facility--has resulted in studies on the
effects of the Skylab gas mixtures on general health and immunocompetence
of mice and ferrets subjected to the Skylab space cabin environment (SCE).
Preliminary experiments were performed at the Illinois Institute of Technology,
Research Institute (IITRI) to determine initial tolerability of ferrets
maintained at gas ratios of 30% nitrogen and 70% oxygen under 5 psia.
Depression of immunologic responses related to stress of the initial event
(decompressing to 5 psia) were evident at 7 days after introduction into
Skylab environment. Recovery to normal response was apparent by 21 days
exposure. This evidence consisted of decreased lymphoid organ weight and
reduced response to antigenic stimulation. Also in preliminary experiments,
it became apparent that histologic changes in the mucociliary system of the
upper respiratory tree were attributable to high levels of ammonium arising
from animal waste due to low turnover rates of gas environment.
Thus, a stainless steel low pressure facility which consisted of
2 subchambers, that permitted mutual isolation of experimental groups
and/or selective removal of animals without return of the entire cabin to
ambient pressure was developed. Throughout experimental tests, the chamber
environment was stable, fluctuating only 4-6 mm Hg in pressure and 1-30C in
temperature. Upon ascent to altitude, neither young adult mice, ferrets,
nor suckling mice indicated signs of bends.
Mice subjected to the 70:30 02:N2 and 5 psi cabin environment,
had severely reduced thymic weights 3 days after exposure to cabin atmosphere.
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In ferrets, spleen weights were most affected by ascent to altitude; thymus
weights remained relatively unchanged. Control ferrets housed in rigid
glass isolators with absolute filters also showed a similar trend in splenic
weights due to stress factors related to the enclosed environment. Animals
housed in the open did not show these changes.
Murine hepatitis virus (MHV3) infection in SCE did not appear to
be enhanced, whereas influenza virus infection was. Since humoral anti,pody
response is a major factor in MHV 3, control of this hepatitis may be a,
response of primarily B-type lymphocytes. The fact that mice which had
reduced thymic weights and not reduced splenic weights indicate a prerequisite
for reduced resistance to influenza virus. This apparently involves T-cell
or combined T- and B-cell function as opposed to MHV3 which is known to
elicit humoral antibody. In mice, as indicated by normal spleen weights
and normal humoral antibody response, this limb of the immune system was
unaffected by SCE.
Our studies have clearly demonstrated that ferrets immunized with
Brucella Strain 19 prior to being housed in SCE had decreased synthesis of
IgG compared to their respective controls. Separation of IgG from IgM was
accomplished by inactivation of IgM with mercaptoethanol. Chamber stresses,
therefore, had affected humoral antibody activity in the ferrets, as indicated
by reduced spleen weights and decreased IgG synthesis.
Because of the possibility of latent infections being responsible
for stress-induced upper respiratory diseases of astronauts, the role of
neutralizing antibody as a function of antibody affinity/avidity was investi-
gated. The model consisted of Aleutian disease virus (ADV) which infects
ferrets and mink resulting in nonneutralized immune complexes. These
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studies demonstrated that early antibody to ADV had lower affinity/avidity
than late antibody with respect to chronicity. These studies culminated in
a description of antibody affinity, first isolation of ADV and its cultiva-
tion in vitro.
Since passive immune aggregation represented an approach that may
be used to detect subclinical viral infections in astronauts, this procedure
was studied as a possible means of rapid detection of lymphoproliferative
viruses. Preliminary analyses have indicated the procedure described~in
contract NAS 9-11371, Microbial Ecology Measurement System, was unworkable
due to dissociation of antibody from insoluble supporting matrix. As in
affinity chromatography (immunoadsorption) the antibody must be covalently
bound to the supporting material to prevent new adsorption equilibria from
being established when exposed to antigen.
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IV. INTRODUCTION - PRELIMINARY ANALYSES AND EVALUATION OF SPACE CABIN
ENVIRONMENTS ON FERRET RESPIRATORY SYSTEM.
The frequency of "minor colds" experienced by astronauts in
flight and the experimental evidence of altered susceptibility to respiratory
disease in mice exposed to space cabin environments prompted consideration
of depressed physiologic and immunologic responses as a result of spacecraft
environmental stress. Factors of importance in the induction of respiratory
disease are the depression of normal immune mechanisms and the function of
the mucociliary system. The muscosal movement of inhaled particles by
ciliated cells could be impaired in the spacecraft environment. Reduced
atmospheric pressures cause differences in aerodynamic equivalent diameters
of particles. This, coupled with aerosal aggregation which occurs at zero
gravity, alters the pathogenic character of aerosols.
In the initial considerations of disease transmission, it seemed
important to study the immunologic and physiologic effects of small animals
exposed to a simulated spacecraft environment. In these considerations, it
also seemed important to dilineate the function of pressure in respiratory
physiologic response to inhaled particles; to experimentally establish the
effect of the spacecraft environment on the median aerodynamic mass of
aerosolized inert and infectious particles; and to measure the rate of
elimination of inhaled organisms in relation to reduced mucociliary clearance
and altered alveolar macrophage function.
Although the methodology was available to undertake a study of
factors relating to respiratory physiology and disease transmissions, the
following preliminary study was developed at the Illinois Institute of
Technology, Research Institute (IIIRI).
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The objectives of this study were:
1. Obtain evidence of signs of stress associated
with the chamber environment.
2. Relate stress factors to physiologic and
immunologic predisposition to disease.
The experimental design consisted of placing 14 ferrets in simulated
spacecraft environment as proposed and used in the Skylab missions. The
environmental conditions were 30% nitrogen, 70% oxygen, 5 psia, relative
humidity 50%, temperature 260C. Control subjects (14 fe'rrets) were housed
in animal in similar cages, but at ambient conditions. At time zero, when
the animals entered the chamber, 2 ferrets from each group were sacrificed,
and the following analyses made. On blood, a complete hemogram was obtained,
while on serum hemagglutination of sheep RBCs, serum protein profile (electro-
phoresis) and serum enzyme levels were determined. At necropsy, body
weights and all organ weights were obtained. Tissues were fixed in 10%
formaldehyde as well as frozen. On fixed tissues, H and E stains and
mucicarman stain were performed. Particular enphasis was placed on the
respiratory system using mucicarman stain and analysis of respiratory muco-
ciliary system. The tests performed are listed in Table 1.
Animals and the animal caretaker entered the chamber together to
set up cage arrangements (the animal caretaker used an oxygen mask and
prebreathed 100% oxygen during ascent to altitude (30 minutes). The configura-
tion of the chamber is shown in Figure 1 and control panel in Figure 1'.
During the test period, chamber performance was as indicated in Table 2.
The experimental design is shown in Table 3.
TABLE 1
TESTS PERFORMED
Blood Serum
Hematocrit Hemagglutination
WBC Serum protein
RBC Electrophoresis
LDH Isozymes
ALK Phosphotase
Intact Ferret - Body wt.
Organ weights on necropsy
Tissues (Fixed) Tissues (Frozen)
H & E stain on section Immunofluorescence
Mucicarman stain (lung and lymph nodes)
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TABLE 2
RECORD OF ENVIRONMENTAL CONDITIONS IN TEST CHAMBER
A simulated altitude of 27,000 feet + 500 feet (5 psia) was maintained.*
Date 02% C02% Temp.oC R.H. %
7-27-71 68 2.0 26 48
7-28-71 69 2.1 23.5 50
7-29-71 72 2.0 25 48
7-30-71* 70 2.1 23 65
8-02-71 76 2.1 18 49
8-03-71 66 2.1 24 46
8-04-71 65 , 2.0 20 62
8-05-71 69 1.9 23 58
8-06-71 72 1.9 23 52
8-09-71 72 2.0 21 51
8-10-71 68 2.0 22 52
8-11-71 71 1.8 21 51
8-12-71 76 1.7 21 51
8-13-71 73 1.8 21 51
8-16-71 75 1.7 21 54
8-17-71 72 1.7 21 51
8-18-71 72 1.7 21 51
8-19-71 70 1.6 21 51
8-20-71 70 1.4 22 48
8-23-71 75 1.1 22 52
- 71.1 1.8 21.9 52.1 average
*8-31-71 Malfunction of automatic vacuum control.
Chamber lost vacuum to sea level.
TABLE 3
EXPERIMENTAL DESIGN
Day Open Chamber
0 2
1 2 2
3 2 2
7 2 2
14 2 2
21 2 2
28 1 1
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The results of this study were as follows:
Body weight - In both control and test subjects, the ferrets gained
weight over the 28-day period. The average weight for both groups was 550
g and at the end of the test period, the control was 880 g, while the test
group was only 680 g. Early in the course of the chamber exposure (day 1)
the average weight was less than the starting weight which may have resulted
from dehydration (Figure 2).
Lymphoid organ weight - Both the thymus and spleen weights decreased
markedly in the chamber group. This reduction in weight was evident in the
first week of test which suggests that induction into the SCE was stressful.
The values shown were placed on percent of body weight which tends to mask
the reduction because of overreduced body weight. However, these changes
in lymphoid organ weight are still significant (Figures 3 and 4).
Weight of control organs - Liver and kidney weights were also taken so
as to monitor weight changes of organs which have relatively little stress-
association. As shown in Figures 5 and 6, as the ferrets gained weight;
the relative size of the liver and kidney decrease with no noticeable
change occurring in the first week of exposure.
Red blood cell count - The RBC level averaged 5.9 x 106 at zero time
and rose to 6.1 x 106 for the chamber group. This rapid increase may be
associated with dehydration of the test subjects. At day 7, both groups
had similar levels (7.4 chamber; 7.6 controls); however, at the end of the
period, the test group had 5.9 and the control 7.4 (Figure 7).
White blood cell count - During the first week of exposure, the test
group had a lower WBC count than did the control groups (at days 3 and 7,
test had 4,000 and 4,800, respectively; whereas the ambient group had 5,100
and 7.900, respectively). Again, as anticipated under stressful conditions,
the WBC count had decreased (Figure 8).
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Enzyme assays - The enzyme assays shown in Table 2 were performed on
both groups. No significant changes were observed in serum enzyme levels.
Hemagglutination assay - A pronounced difference existed in antibody
response of the chamber animals compared to controls. At day 3 to day 14,
the antibody production to sheep RBCs was reduced to zero due to lack of
IgG synthesis. The antibody level of the control group remained relatively
constant through the 28-day period; whereas the chamber group reacted to
the stress by cessation of antibody synthesis and then recovery by dayt%21
through day 28 (Figure 9).
Histologic evaluation of lymphoid tissue - Sections made of splenic
tissue on 3 and 7 days post-exposure to SCE revealed a greatly reduced
number of germinal centers being formed in the splenic follicles; whereas
the control had strong signs of antigenic stimulation. These changes
support the concept of a reduction in immunocompetence as the result of
stress and support other observations such as reduced hemagglutination
level, reduced WBC count, and reduced lymphoid organ weight.(Figure 10).
Histologic changes of mucociliary system - During the course of this
mission, sections were prepared from representative areas of the respiratory
tree and lung. In sections taken at 7, 14 and 21 days post-exposure to
SCE, it became apparent that there was reduced secretion of the goblet
cells as demonstrated by mucicarman stain. Also, these appeared to lessen
height to the ciliary blanket. These changes were very apparent as seen in
Figures 11 and 11' of bonchus sections from chamber and control animals.
During these experiments it became obvious that the IITRI chamber had
inadequate gas/chamber volume turnover or circulation of filtered gas. The
ammonium level reached objectional levels in the antichamber (ambient lock)
during removal of animals on test days when the lock was brought to ambient
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conditions. Thus, many of the changes associated with the respiratory
system may be directly related to ammonia toxic from urinary waste.
In conclusion, regarding preliminary experiments conducted at
IITRI, the following became apparent:
1) The induction of ferrets into a SCE was stressful.
2) There occurred a reduced immunologic responsiveness associated
with the initial events.
3) These changes could be easily documented in organ weighZ;,
serology and histology.
4) The histologic changes observed in the upper respiratory
tree are likely the result of low gas/volume exchange in the
space cabin simulator.
Figure 9
HEMAGGLUT I NAT ION
Ambient
Chamber
100 - - --
90
80
70
/o
60.-
/
40
S40 f
30 /
20
10
- -Dy
Days
Figure 10
Splenic Follicle from Control Group
Splenic Follicle from Chamber Group
This figure depicts the lack of immunologic reactivity of splenic
follicle of ferrets SCE after 7-14 days.
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The top histologic section (mucicarman stain) shows normal development
of mucociliary system, whereas in the bottom photpgraph the goblet cell
secretion is greatly reduced.
Figure 11
Bronchus Control
-
Bronchus Chamber Group
The top histologic section (mucicarman stain) shows normal development
of mucociliary system, whereas in the bottom photograph the goblet
cell secretion is greatly reduced.
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V. CHAMBER DEVELOPMENT
A. SPECIFICATIONS SOUGHT IN CHAMBER DESIGN
1.0 GENERAL
The purpose of this specification is to provide guide lines in the
construction of a reduced pressure test facility to be installed at
the University of Connecticut. The statements as to function are the
minimum requirements and standard components or changes that will
economically improve performance incorporated.
1.1 PURPOSE OF SYSTEM:
This unit is designed to hold at least 20 ferrets, either free or in
cages at test conditions for a minimum period of 180 days. The animals
must be maintained at the test conditions during feeding, cleaning,
and selective removal of animals for examination. The system will
operate on an open cycle at present but must be capable of easy modifi-
cation to a closed cycle.
1.2 OPERATING PARAMETERS:
The chamber will operate with an atmosphere varying from air to 70%
oxygen and 30% nitrogen supplied from an outside pressure source. The
operating temperature will be 20 to 370C and relative humidity from 50
to 75%. The operating pressure will be from 760 to 200 mm Hg. A gas
input of up to 2 scfm of an oxygen - nitrogen will be used that will
be dry. The capacity to remove animals, move them from one chamber to
another, feed and clean them is required. Manipulators as outlined in
Section 3 will be used. The present system will operate under semi-
automatic control as outlined in sections 5, 6, and 7 but will be
converted to automatic control and recording at a later date.
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1.3 RELIABILITY:
Due to the length of the test (180 days) and operating conditions, the
unit must be designed to fail safe. The value of the test subjects
increase with time and all equipment of utility failures should return
or maintain the animals in a liveable atmosphere. It must be possible
to isolate a failed component and replace it without aborting the
test. Types of failure to be anticipated are, but not limited to:
a. Controller failure
b. Gas supply failure
c. Valve failure, open or closed
d. Power failure
1.4 PERFORMANCE SCHEDULE:
(After date of award)
0 Weeks
2 " Preliminary sketches
4 " Schematics, flow sheets, material ordered
8 " Full design drawings
12 " Construction complete
16 " Delivery
18 " Acceptance
2.0 MAIN LOCK:
The main lock (2 required) will hold the 20 loose or caged ferrets.
2.1 SIZE:
The lock will have a working space of 30 x 30 x 48 inches long.
2.2 ACCESS:
One end will have a full opening door and the other a lock.
Eight (8) 2 inch spare couplings will be on the rear wall for
instrumentation and future use. Sufficient couplings are to be
provided for necessary operating connections.
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2.3 CONSTRUCTION:
The interior will be of 304 SS with all welds ground smooth and passivated.
All internal fitting will be noncorroding. One wall will be transparent,
and there will be a 3-inch view port in the main door.
2.4 Each lock will have manipulators as outlined in Section 4 and an air
handling sytem as outlined in Section 5.
3.0 INTERCONNECTING LOCK:
Between the two main locks is an interconnectilng lock. This!,unit is
to facilitate the transfer of cages, animals and food so that the one
main lock can be evacuated and ther other raised to atmospheric pressure.
3.1 This unit must handle a cage of 11 x 11 x 23 inches. Animals must
be able to walk through or cages pushed through the lock.
3.2 The lock door should pressure-seal, if possible, to reduce
leakage and swing completely out of the way to provide
mobility for the animals and cages.
3.3 If the lock is longer than 12 inches, a view port must be provided.
4.0 MANIPULATORS:
Two types of manipulators are required for each lock. The units must
be easy to use and functional. When not in use, they must not protrude
into the interior or exterior of the chambers.
4.1 Two (2) manipulators will be provided for each main lock. Their
purpose will be to pick up animals and place them in cages, move cages
or transfer them in and out of the interconnecting lock. They must
sweep the entire floor area of the chamber.
4.2 One (1) manipulator will be provided that will force free animals
within the chamber to move from the main lock to the interconnecting
lock. This unit should be flush with the front door and sweep the
entire floor area, pushing the animals into the lock. When not in
use, the operating mechanism should be removed and the interior section
should be flush with the front door.
5.0 TEMPERATURE, HUMIDITY CONTROL:
Due to the fact that the gas flow will be low, humidity is expected to
rise; however, for small animal populations, the humidity may drop due
to the dry gas input.
5.1 TEMPERATURE CONTROL:
20 to 370 C plus/minus 20, the temperature will be maintained close to
the ambient room temperature 220C 65% RH, however, slight deviations
are expected. A temperature control and readout are to be provided
utilizing a coil and blower assembly inside the main lock not occupying
more than 1/2 cubic foot.
5.2 Humidity control 50 to 75% RH plus/minus 5% RH must be maintained at
250 mm Hg pressure. Humidity will be reduced through the use of cold
coil and raised by adding moisture to a pad in the inlet gas line.
The cold coil will have a drain that will be emptied to atmosphere.
A humidity controller and readout will be provided reading in % RH.
6.0 ATMOSPHERIC PRESSURE CONTROL:
This system will maintain the unit at a test point from 250 mm Hg to
760 mm Hg plus/minus 10 mm Hg.
6.1 A vacuum pump, pressure controller and readout will be provided with
the system.
6.2 The unit will be capable of pumping the system down in 15 minutes and
handle a steady flow of 2 scfm for 180 continuous days.
6.3 A readout of pressure will be available for all three locks if required.
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6.4 Changes in pressure will be modulated and capable of hand control.
6.5 The vacuum pump will not back stream oil and be compatible with 100%
oxygen.
6.6 The vacuum pump can be isolated from the system and serviced if required.
6.7 The pressure of the chamber cannot go below 20 mm Hg of set point
under any circumstances.
6.8 The pressure of the chamber cannot go above 780 mm Hg.
7.0 GAS CONCENTRATION CONTROL:
The purpose of this system is to maintain a liyeable atmosphere for
the test subjects.
7.1 The operating atmosphere of 70% oxygen and 30% nitrogen will be supplied
from a pressure source supplied by the Laboratory at a rate from 0 to
2 scfm of either gas.
7.2 The oxygen concentration will be controlled by an oxygen sensor that
has an accuracy of plus/minus 2% over a range of 2 to 200 mm of oxygen
in any background gas.
7.3 The controller will have a readout in mm oxygen and an off-on control
for admitting the correct gas to maintain operating conditions.
7.4 The sensor will not require replacement during the 180-day test or be
continuously recalibrated and be insensitive to pressure changes.
7.5 The system will be compatible with conventional recorders.
7.6 The gas valving shall be such that on a controller failure, the atmosphere
will remain habitable for the animals.
7.7 The gas valving shall permit operation of the system manually with
empirical data secured from flow meters supplied with the system.
Micrometering valves and pressure compensated flow meters will be
provided.
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8.0 APPLICABLE CODES:
8.1 The pressure portion of the system will be designed and constructed in
accordance with applicable ASME Code Section VIII Unfired Pressure
Vessels.
8.2 Electrical portions of the chamber will be in accordance with NFPA
Code 56 and 70 and NEMA Standards.
9.0 ACCEPTANCE:
9.1 Acceptance tests outlined in Appendix 1 will be run and testtdata
furnished to the chief investigator for final elease.
9.2 One (1) reproducible copy of wiring schematics, flow sheets, and
piping diagrams will be provided.
9.3 Assembly drawings and schematics will be approved prior to construction
and any changes will be approved by the chief investigator.
9.4 Utility requirements will be established 30 days after date of award.
9.5 The manufacturer's engineer will be present during start-up of all
tests and be available for training personnel on the use of the equip-
ment until final acceptance.
10.0 APPENDIX 1 - ACCEPTANCE TESTS:
The purpose of these tests is to assure the customer that the unit
will perform as requested.
10.1 VESSEL INTEGRITY:
The chamber will be evacuated to 250 mm of Hg and all valving closed.
Pressure will not rise more than 100 mm Hg in 15 minutes.
10.2 The chamber will be controlled at a pressure of 250 mm Hg for 48 hours
and there will not be a variation of more than 20 mm of Hg during that
time.
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10.3 The chamber will be set at 300C and 65% RH and held at that point for
48 hours at 250 mm Hg within specifications.
10.4 The gas concentration will be set at 70% 02 and 30% N2 at 250 mm Hg
and held for 48 hours with a constant flow of less than 2 scfm.
Note: Tests 10.2, 10.3 and 10.4 can be run simultaneously.
10.5 MANIPULATOR FUNCTION:
With the chamber at 250 mm Hg pressure, animals will be transferred
from lock to lock and placed in the cages utiliizing the manipulators.
10.6 FAILURE TESTS:
Unit will be operating at 250 mm Hg 70% 02 and 30% N2.
10.6.1 Power turned off - the system will return slowly
to atmospheric pressure.
10.6.2 Inlet gas supply fails - the unit will return to
atmospheric pressure.
10.6.3 Oxygen controller will fail high and low.
The oxygen concentration will not go below 160 torr.
10.6.4 The vacuum control will fail open. The pressure
will not drop below 20 torr of set point.
10.6.5 On all above modes of failure, alarm contacts will
close and remain closed until reset.
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B. GENERAL DESCRIPTION OF CONSTRUCTED HYPOBARIC CHAMBER
The hypobaric chamber was capable of holding small animals (mice
or ferrets) for long-term studies at partial vacuums to 5 psi for at least
180 days. A gas mixture of 70% 02 and 30% N2 was maintained by an oxygen
analyzer (described below); temperature (range: 15-370C) and humidity
(range: 50-75%) were controlled by appropriate regulators (described below).
The chamber was 9-feet long and fabricated from stainless steel
(304 B SS) to comprise of 2 subchambers, each 4-feet long, joined by an
interconnecting lock (see Figure 12, photograph of chambpr). A subchamber
permitted great flexibility in experimental designs. Namely, a control
group could be housed on one side of the chamber opposite from the test
group and retained at ambient pressure, thereby subjecting controls to
identical conditions of confinement. Further, animals could be selectively
removed without returning the entire cabin to ambient pressure (see Figures
13-17 for schematics).
The chamber was constructed to allow for minimum leakage--all
welds had been ground smooth and passivated. Internal fittings were non-
corroding to prevent moisture and/or ammonia from causing chamber deteriora-
tion. The front wall of each subchamber was reinforced 1-inch thick aircraft
grade Plexiglas, to facilitate surveillance of experimental animals.
Subchambers had a working space of 30" x 30" x 48" joined by an interconnecting
lock, containing 2 inner doors; during operation of a single subchamber,
one door of the lock was closed to insure that the gasket was pressure-
sealing. External access to each subchamber was a full-opening door fitted
with 2 pressure-sealing gaskets with a middle anulus.
Movement of animals between subchambers was accomplished by a
pair of finger-like manipulators (sealed with "0" rings). The manipulators
Figure 12
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were spring-loaded, and protruded from the top of each subchamber; these
units had the capability of sweeping the entire floor, and could be lifed
from the subchamber when not in use.
Two drainage locks were installed in the bottom of the chamber
which permitted draining the chamber and relative humidity controller
overflow pans. Numerous safety devices had been included on the chamber,
such as safety valves, lights, and alarms, which were activated by pressure-
sensitive switches whenever loss of electrical power and/or unsafe reduction
in either 02 or N2 occurred.
Since the major systems are complex, following is a description
of the operating parameters used in the simulated Skylab cabin, after which
the major component systems will be described in more detail.
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C. SKYLAB ENVIRONMENT - OPERATING PARAMETERS
Gas was supplied by external tanks with a 70:30 02 :N2 mixture
controlled by an oxygen analyzer. Air turnover rate was 2-4 changes per
hour which at 5 psi is equivalent to 6-12 changes/hour. During most
experiments, 17.0 standard cubic feet per hour (scfh) of 02 was used,
and approximately 7.5 scfh N2 . Nitrogen was also used to drive the valve
on the vacuum pump, bringing total N2 consumption to approximately 16.0
scfh. Routinely, temperature was maintained between 18 and 24 C, and,,
relativehumidity between 30 and 60%. Both the temperature and relative
humidity deivces had self-contained regulator switches, which were set
to operate at desired experimental conditions. Temperature was adjusted
to meet species requirements, but also fluctuated directly with changes
in relative humidity. Chamber pressure 504 mm Hg + 3 mm when operating,
which is equivalent to approximately 34% of an atmosphere, or 5 psi.
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D. MAJOR SYSTEMS COMPONENTS
The major components of the hypobaric chamber were a vacuum pump,
temperature and humidity control devices, and an oxygen analyzer (Figs. 4-
7). Overriding mechanical control was included on all these components to
insure stability within the chamber, but adjustments could be made manually
during chamber operation.
The vacuum pump evacuated the chamber to the pressure selected on
the pressure controller. A hand valve on the chamber front determinedt
which chamber was connected to the vacuum system, and aivent valve was
included for rapidly returning the chamber to ambient pressure. If the
pump was turned off or power was lost, a solenoid valve closed, thereby
temporarily preventing loss of vacuum to the chamber. Repairs were made on
the vacuum pump by shutting the gas inflow valves; vacuum was held for 12
hours during chamber performance tests of this nature. During normal
operation, the pressure controller was set at 504 mm Hg; as an additional
control, when the vacuum was above 524 mm Hg, a solenoid valve turned off
the vacuum pump. During usual operation, when the desired vacuum was
attained, a throttling valve restricted the flow of gas to the pump,
thereby maintaining the desired cabin pressure.
Temperature was regulated by a controller which activated either
a heater, or, upon high temperature, contacts closed an energizing solenoid
valve allowing cooling water to flow through the coil. Shut-off of the
internal heaters occurred when the temperature reached above 850 C. Closely
related to temperature control was the relative humidity system. Relative
humidity was increased by admitting distilled water into the chamber, and
was decreased by activating the cooling coil of the temperature system,
which then condensed the excess moisture. If, as a result of this compensa-
tion for high humidity, the temperature dropped, the heater was activated
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and air reheated. Both temperature control and humidity control systems
have switches which determine which side of the chamber if monitored.
Oxygen concentration was controlled by an oxygen sensor which had
and accuracy of + 2% over a range of 2 to 200 mm of oxygen in combination
with any gas. Concentrations of 02 were regulated by a solenoid valve
which admitted N2 whenever necessary to maintain the planned gas mixture.
When the controller was operating, internal fans were running to permit
mixing of the gases; these fans also served to stabilize the cabin atmosphere.
Safety features which were included so that in the event;of controller:
failure, the atmosphere would remain habitable by shutting off N2 flow.
Similarly, if the vacuum pump failed, 02 continued to flow into the chamber,
slowly bringing the chamber to ambient pressure.
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E. OPERATION MANUAL
1.0 GENERAL
This operating manual describes the function and operation of the
components. Every attempt has been made to furnish full and
complete instructuon. Should conditions arise that are not
covered, please contact the contractor at the Sloan-Kettering
Institute, New York for further information or consultation.
Full brochures covering the subassemblies had been provided.
Failure to read and observe their requirements: may result int.
damage to the components of the entire system,. The manufacturer
recommended that the entire manual be read prior to operation.
1.1 PURPOSE OF SYSTEM
The chamber is designed to house animals for long-term studies at
partial vacuums to 5 psia. The oxygen concentration should not
exceed 70% at 5 psia. The temperature should be maintained from
180 to 370C and the relative humidity at approximately 65%.
1.2 METHOD OF OPERATION OF SYSTEMS
A vacuum pump evacuates the chamber to a pressure selected by the
pressure controller. When the set pressure is reached, a throttling
valve restricts the flow of gas to the pump.
Oxygen input is set by adjusting a flowmeter on the control
panel. If the oxygen content of the chamber is high, the oxygen
controller admist nitrogen into the system. During normal operation
there is always a flow of oxygen into the chamber. Temperature
is regulated by a controller activating either a heater of valve
admitting cooling water to a coil. A high temperature limit
cutout is provided.
Relative humidity is controlled by admitting distilled water to a
pad on low humidity or activating the cooling coil on high humidity
to condense the moisture. Should the temperature drop, the
heater will reheat the air.
1.3 METHOD OF OPERATION OF LOCK
The inner doors raise when the handles on the top of the chamber
are rotated clockwise. During operation, only one door should be
closed, so that the gasket is pressure-sealingi
1.4 MANIPULATORS
The chamber has 4 manipulators to facilitate the moving of the
cages or animals about. These units are sealed with "0" rings
and can be extended or retracted. Springs force the fingers to
open and can be reversed or removed if desired.
1.5 DRAINAGE LOCKS
Below the chamber are 2 drainage locks. They permit draining of
the chamber, pan and relative humidity overflow without venting
the chamber. The upper valve is normally open and the lower
valve is closed.
2.0 INSTALLATION
The unit should have the following utilities:
1. 200 volt - 60 cycle - 30 amp service.
2. 3 to 5 gallon/minute cooling water 50 psia "3/8" for vacuum
pump and cooling coils.
3. 50 psig min nitrogen supply 10 cfm 1/4 tube.
4. 50 psig min oxygen supply 10 cfm 1/4 tube.
5. Distilled water supply for relative humidity control.
1/4" tube.
6. Vent to exterior for vacuum pump exhaust 1/2" hose.
7. Drain for cooling water out and for drain locks on chamber
1-1/2" line.
3.0 START UP
3.1 Be sure all the installation steps have been followed.
3.2 Check level of oil in vacuum pump - at least one inch should show
in sight glass.
3.3 Turn on cooling water.
3.4 Close main switch. All other switches should be in the "off,
position. All warning lights should be on. (See 4.0)
3.5 At this point all valves on panel should point'vertically up.
This is the closed position.
3.6 Turn on vacuum pump; pump should start and cooling water begin to
flow.
3.7 Select pressure to be operated at (refer to controller instruction
manual).
3.8 If only one chamber is to be drawn down, close the required
doors.
3.9 Turn vacuum to chamber valve (HV-16) and pressure selector valve
HV-17 to point to the left or right determined by the choice of
chamber to be evacuated. NOTE: Both valves must always point
in the same direction. Failure to do so will prevent the con-
troller from monitoring the correct chamber and possibly damage
the system.
3.10 The chamber will now lower in pressure.
3.10 At this time the setting of the other controllers should be
checked out and the rest of the system turned on.
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4.0 ALARMS AND SAFETY DEVICES
4.1 There are 4 warning lights on the console and a bell that is
activated after an emergency condition arises for more than 3
minutes. Two lights are effected by chamber pressure opening
when the vacuum exceeds 520 mm. Hg. Two lights open when the 02
or N2 supply pressure drops below 50 psig.
Upon alarm (after 3 minutes) the control valve will close and
cannot open until the defect is corrected. Refer to wiring ,
diagram UC-4.
4.2 There are 2 pressure-receiving valves at the rear of the chamber
that prevent positive pressure from occurring inside the chamber.
4.3 There are two high temperature cutout thermal switches that will
disconnect the heater if chamber temperature goes above 850F.
All of the above devices can be regulated by referring to the
instructions supplied.
5.0 VACUUM SYSTEM
5.1 Referring to drawing UC-2:
The vacuum is drawn by the pump through control valve CV-1. The
selector valve HV-16 determines which chamber will be connected.
There are two throttling valves HV-12 and 13 which can regulate
the flow thru the central valve.
On alarm, SV-2 is de-energized removing the signal from the
control valve and closing it.
Should control valve CV-1 be inoperative, there are two bypass
hand valves that can provide manual function.
When the pump is turned off or power is lost, SV-1 opens, venting
the vacuum pump to permit easy starting and prevent oil back-
streaming.
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HV-17 determines what chamber pressure the instrument will see:
NOTE: Both HV-17 and HV-16 must be pointed in the same
directions on the control panel at all times.
Vent valve HV-7 is available to rapidly vent the chamber.
5.2 The controller received its controlled air from the nitrogen
supply via regulator R-3 mounted next to the control valve.
6.0 GAS SUPPLY SYSTEM
6.1 Oxygen and nitrogen are supplied from K or liquid cylinders at
50-60 psig through the rear panel. The gas it then passed through
filters (mounted below the chamber).
6.2 The nitrogen line has a bleed connection (item 25) connected to
pressure switch PS-1 and regulator R3 and then goes to the solenoid
valves SV-7 and 8 with their bypass valves HV-1 and 2.
The panel of mounted flowmeters indicate flow into the chamber as
regulated by HV-3 and 4. To set the flow, open the correct
bypass valve and adjust the panel-mounted valve. When the oxygen
controller calls for nitrogen, the solenoid valve will operate.
6.3 The oxygen line has a bleed connection (item 25) connected to
pressure switch PS-2 and then goes to the panel-mounted flowmeters.
This is set by simply adjusting panel-mounted HV-5 and HV-6.
7.0 TEMPERATURE CONTROL SYSTEMS
7.1 Switch 6 turns on the fan in chamber A and switch 8 energizes the
temperature controller on low temperature; contacts close energizing
heater H-1 mounted inside the chamber. On high temperature,
contacts close energizing solenoid valve SV-3 allowing cooling
water to flow through the coil. A hand valve is provided to
adjust the flow for rate of temperature drop.
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7.2 Switch 7 and 9 perform similar functions for chamber B.
7.3 High temperature cutout: shut off the internal heaters if the
temperature is above 850F.
8.0 RELATIVE HUMIDITY CONTROL SYSTEM
8.1 Switch 10 turns the humidity controller to a functioning position,
switch 11 selects the appropriate chamber.
8.2 After setting the controller limits, when the R.H. is above the
high set point, the cooling coil water flows, condensing moisture.
When the R.H. is below the lower set point, water flows into the
coil area.
8.3 Should the cooling coil during its dehumidification cycle drop
the temperature, the heating coil will automatically be engaged.
9.0 OXYGEN CONTROL SYSTEM
9.1 Set the oxygen partial pressure upper limit. Using hand valve
24, select the chamber to be monitored. Turn on controller.
Referring to the directions, adjust the flow after the warm-up
period by the valve on the panel-mounted flowmeter.
9.2 When the controller is operating (refer to instructions), set the
oxygen input flowmeter to the desired flow. When the concentration
of oxygen exceeds the set point, the nitrogen SV-7 or 8 will
open. Adjust Nitrogen flow. During the oxygen control, the
internal fans must be running to permit mixing of the gases.
9.3 When the oxygen meter is turned on, a pump will start. This pump
raises the gas from partial vacuum to ambient so that an accurate
reading of the meter is obtained. The partial pressure reading
on the meter is referenced at ambient pressure.
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10.0 MAIN COMPONENTS
1. Vacuum Pump Main
Beach-Russ Size #1-1/2-D Type SS rotary single stage. 1 HP
Motor Unit has been filled with: Houghto Safe 1010 manufactured
by E. F. Houghton & Co., 303 W. Lehigh Avenue, Philadelphia,
Pennsylvania 19133, Telephone 215-739-7100. Use only this
type - phosphate ester, due to oxygen service.
2. Vacuum Pump Oxygen Sensor Supply, Metal Belilows Corporation,
Pump MB-155, SN #15-194, 1075 Proficence Hilghway, Sharon,
Massachusetts 02067.
3. Fisher F4152-2C9, Low Pressure Controller, 4150X2-Al-BI-D6-
E10-Fl-Gl-Hl-Jl-Kl-L1-Nl-P1.
4. Fisher Valve with F5513R-13, Activator, 1/2" type 513R-GS
G5XI-Al-B17-C50-D1-El-Fl.
Fisher Controls Company, Marshalltown, Iowa 50518
5. Temperature Controller -40 to 50C, UE Type 802P Model 4BS
6. Vacuum Switches, 0-30" vacuum, UE Type H54 model 22
7. Pressure Switches, 10 to 100 psig, UE Type H54 model 25
United Electric Controls Company, 85 School Street, Watertown,
Massachusetts 02172, Telephone 617-926-1000.
8. Flowmeters, F. W. Dwyer Mfg. Co., Inc., P.O. Box 373, Michigan
City, Indiana 46360, Telephone 219-872-9141 No. RMB-54
range 20-200 scfh air.
9. Gauges, Heise Bourdon Tube Co., Inc., South Main Street,
Newtown, Connecticut 06470, Telephone 203-426-4406 #CM-
7779-7780.
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10. High Temperature Cutout Model AIS Code 161, Burling Instrument
Company, P.O. Box 298, Chatham, New Jersey 07928, Telephone
201-635-9481.
11. Relative Humidity Controller, Environmental Devices, Inc.
Amlab. Instrument Division, Ivoryton, Connecticut 06442,
Model HIC-2 with 2 sensors, Zach Abbey.
12. Oxygen Analyzer, Model 11 System/pump, Thermo-Lab Inst.,,
Inc. 1308 Wm. Flynn Highway, Rt. 8, Glenshaw, Pennsylvania
15116, Don Sayles.
(For details see schematics, Figures 13-17.)
Figure 14. Chamber Schematic:
Controller Flow Sheet
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VI. SPACECRAFT ENVIRONMENT STUDIES
A. INTRODUCTION
Heightened susceptibility to infection, although having been suggested
by numerous investigators, had not been clearly established with the proposed
gas mixtures for Skylab. The parameters planned for use in the Skylab mission
were a 70:30 02:N2 mixture, which at 5 psi, is equivalent to a partial pressure
of 02 similar to sea level conditions. The studies were undertaken to establish
the effect of reduced pressure on the respiratory clearance system, which was
followed by clearance of titanium dioxide (Ti02) as iner, dust. General immuno-
competence of animals housed in SCE was evaluated by the pattern of antibody
production to Brucella abortus and by in vivo pathogenesis of influenza and
hepatitis virus. Finally, it was of interest to ascertain whether the apparent
stress phenomena is a generalized stress or specifically related to diseases of
the respiratory tract.
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B. MATERIALS AND METHODS
1. EXPERIMENTAL MATERIALS
a. Mice - CD-1 strain mice which were uniform in size.(24-
26g) were obtained from Charles River Breeding Laboratories (Wilmington,
Massachusetts 01887). For most experiments, mice selected were 3-4 weeks
old; when suckling mice were used to conduct studies using hepatitis virus,
they were 10 days old and the litters kept with their dams.
b. Ferrets - All ferrets utilized in hypobaric tests were
obtained from Marshall Research Animals, Inc. (North Rose,, New York 14516).
Animals were pre-bled to assure normalcy, and on the basis of normal immuno-
globulin levels, were determined to be free of Aleutian disease. In the
studies conducted, young female (dark phase) ferrets, weighing approximately
400 g were used.
c. Animal Maintenance - Mice were fed dry, pelleted Purina
Mink Chow (Ralston Purina Co., St. Louis, Missouri). Water was provided by
Ancare plastic water bottles (Ancare Corporation, Manhasset, Long Island,
New York 11030); watering tubes were used in one experiment, but later they
were replaced with special "demand" valves which were essentially leakproof.
Finally, with mice, it was considered necessary to use commercially prepared
moist shipping diet to eliminate the use of water bottles entirely; this
sterile feed was obtained from Charles River Breeding Laboratories (Wilmington,
Massachusetts).
A group of 6 mice (or 10 suckling mice plus dam) was kept to an
11-1/2" x 7-1/2" x 5" polystyrene disposable cage (Maryland Plastics, Inc.,
New York, New York 10016); cage tops were Maryland Plastic's #28 "Econoclid",
which were slightly modified with a larger food hopper. Sawdust and wire
inserts were placed in the bottom of the cages; the wire inserts keeping
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all mice visible even upon death of an animal. Control mice were kept in
the same manner; in the case of the first hypobaric test, the controls were
placed in rigid plastic isolators (Ambient Domes, described below).
Ferrets were maintained on dry, pelleted mink food (G'n Dry Mink
Food, SDR Enterprises, Inc., Andover, Connecticut). Water was admitted
from an external source into a watering dish; water could be admitted at
any time by a switch. Ferrets were "group-housed" in a large, wire cage.
It was equipped with an aluminum sliding door which opened into a pass-'
through, connecting the cage of one subchamber to its mirror-image or
counterpart in the other subchamber. Animals were moved from one subchamber
to the other for cleaning. Selective removal of animals was accomplished
by individually trapping the chosen animals in weighted wire baskets.
Animals intended for later kill periods were retained in the other subchamber.
After the pass-through was removed, the appropriate inner door was closed,
and the selected side of the chamber brought to ambient pressure. This
design permitted maintenance of the experimental groups at altitude, while
still allowing for removal of animals. Control groups were housed in rigid
plastic isolators (Ambient Domes, described below).
2. VIRAL INOCULA
a. Murine hepatitis virus 
- Murine hepatitis virus (MHV3
strain) was obtained from Dr. T. N. Fredrickson (Department of Pathobiology,
University of Connecticut, Storrs, Connecticut 06268). The virus had been
passaged in peritoneal macrophage cultures, and contained 7.6 x 107 plaque-
forming units/ml. Prior to use in this study, it was passaged once in
newborn CD-1 mice. Inoculum used in this study was a 10% homogenate of
infective livers in Medium-199 (Grand Island Biological, Grand Island, New
York).
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b. Influenza virus - Mouse-adapted influenza A/PR-8 was obtained
from Dr. James D. Fenters (I.I.T. Research Institute, 10 West 35th Street,
Chicago, Illinois 60616). The MLD50 (mouse lethal dose) was certified to
be 105.84/0.04 ml.
3. BRUCELLA AGGLUTINATION ASSAY
Sera from ferrets were harvested from blood samples obtained by
cardiac puncture, and frozen in order that all assays be performed simultane-
ously. Antibody titer was determined by standard tube agglutination tests
as follows: Brucella abortus tube antigen (U.S.D.A. Animal Disease Laboratory,
Ames, Iowa) was prepared according to the manufacturer's instructions., To
each tube 0.50 ml serum, plus 1.50 ml tube antigen was added; subsequent
tubes contained 1.0 ml tube antigen, and 1.0 ml was transferred, making
doubling dilutions through 4096. Tubes were incubated at 370C and titer
determined after 24 hours of incubation and at 48 hours.
For differtiating the classes of immunoglobulins, sera were
incubated for 24 hours in 0.10M mercaptoethanol (i.e. 2 pl/0.50 ml) which
reduced the disulfide groups of the 19S components resulting in subunits.
Dilutions and incubation of the sera were identical to that described
above.
4. AMBIENT DOMES
Ambient* control animals (mice and ferrets) for the hypobaric
studies were housed in rigid, 6-foot plastic isolators (6 MP-TmP, The
Germfree Laboratories Inc., Miami, Florida 33133). These units are described
in the Final Report of Contract No. NAS 9-10844, Mod. No. 1S-Studies of
Effects of Closed Microbial Ecology, 180-Day Test Period. The ambient domes
*The term "ambient" refers to the atmospheric pressure encountered at
Storrs, Connecticut.
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were used to provide animals with air flow and temperatureequivalent to
that of the hypobaric chamber. Sterility was not maintained in ambient
domes because it was not relevant to the problems being investigated,
namely, pressure changes and gas mixtures.
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C. EXPERIMENTAL DESIGN
1. HYPOBARIC EFFECT ON MICE
Five experimental groups were included in this experiment (see
Table 1 for description of groups). Groups I and IV were placed in nest
boxes in the hypobaric chamber; in each test the ascent rate was near 1,000
ft/min for the first 3 minutes, then slowed to approximately 500 ft/min
until the 27,000 foot altitude was attained. Groups II, III, and V were
held in ambient pressure domes, having environmental parameters (tempeture
and air movement) similar to the space cabin, except that pressure in the
domes was near that of sea level. Prednisolone (Wolins Pharmaceutical Co.,
Melville, New York 11746; 5 mg/mouse) was given to Group II subjects on
days 0 and 12, in an attempt to establish a maximum stress effect with
corticosteroids. Group IV test subjects had been previously aerosolized
(on days minus 4 through minus 1) intermittently, for a total 24 hour
exposure. Six mice each were scheduled to be killed on days 1, 3, 7, 11,
21 and 28 from the hypobaric groups (Groups I and IV). However, due to
mechanical failure* of the vacuum system on day 4, the experimental design
was slightly modified, as follows: When the chamber was returned to ambient
after 104 hours of operation, the mice planned for the 21 and 28 day kills
in Groups I and IV were used, giving a total of 12 test subjects in Groups
I and IV on day 4 (Table 4 clarifies the modified experimental plan).
Despite return of the chamber groups to ambient pressure on day 4, kill
periods were continued through day 11 for Groups I and IV, and through day
21 for the other 3 groups, as it was thought that a stress event, if occurring
at all, would take place early, and further, this effect could be seen as
*At 96 hours of operation, the seals of high vacuum pump began leaking
diffusion oil, which resulted in lower pumping efficiency, causing re-
peated changes in pressure inside the chamber. It was the manufacturer's
belief that appropriate seals had not been installed to accommodate an
aryl-phosphate ester oil, thus the chamber was brought to ambient pressure
after 104 hours into the run.
TABLE 4. Experimental Design for Hypobaric Test in Mice
Day
Group 1 3 4 7 11 21 28
Ia  6b  6 12 6 6 0 0
II 6 6 6 6 6 6 0
III 6 6 6 6 6 6 0
IV 6 6 6 6 6 0 0
V 6 6 6 6 6 6 0
aExperimental Groups
I Chamber
II Prednisolone
III Control
IV Ti02 - Chamber
V TiO2 - Control
bNumbers represent the number of mice per kill period
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easily upon descent to ambient pressure as ascent to atitude. At kill
periods, complete postmortems were performed on all subjects, body weight,
major organ weights were recorded, and tissues were fixed for histopathological
examination. Portions of lung from Groups IV and V were assayed for Ti02
concentration by the hydrogen peroxide method (see Final Report: Contract
No. NAS 9-11575; Biological Activity of Lunar Soil).
2. HYPOBARIC EFFECT ON FERRETS
In a similar experiment (as described above) a 28-day test run
was completed using ferrets (see Table 5 for experimentall design). All
ferrets were immunized with 0.10 ml (16.50 x 109 cells/ml) Brucella abortus,
Strain 19 vaccine (Colorado Serum Co., Denver, Colorado 80216) intramuscularly
on day minus 5 (5 days prior to introduction into SCE). Group IV animals
had been aerosolized with TiO 2 intermittently for 24 hours (days minus 4
through minus 1), and these animals were marked by tags on chain "necklaces",
to distinguish these animals from the Group I ferrets. Groups III and V
were controls to the Groups I and IV animals, respectively, and were individually
caged, and then placed in the ambient pressure dome. As in the mouse
experiment described above, a group of ferrets was given Prednisolone (10
mg), intramuscularly, on day 0, and they were also placed in isolators.
Aerosolized controls (Group V) to the TiO 2-aerosolized animals (Group IV)
were maintained with other control groups at ambient pressure in isolators.
On the given kill periods, gross postmortems were performed, including body
weight, major organ weight, histopathology, antibody titer to Brucella, and
in Groups IV and V, TiO 2 assays were performed on portions of lung. Five
normal ferrets were killed on day 0 to establish control values; two TiO 2
aerosolized ferrets were killed 24 hours after the last aerosolization
period, to establish baseline values for TiO 2 clearance.
TABLE 5. Experimental Design for Hypobaric Test in Ferrets
Days at Space Cabin Environment
Groupa  1 3 7 12 21 28
I 3b  4 3 3 3 2
II 1 1 1 1 1 1
III 2 2 2 2 2 2
IV 2 2 2 2 1 0
V 1 1 1 1 1
'aExperimental 'Groups
I Chamber
II Prednisolone
III Control
IV Ti02 - Chamber
V TiO2 - Control
bNumbers represeAt the number of ferrets per kill period
3. MURINE HEPATITIS VIRUS INFECTION IN SCE
This experiment was performed in an attempt to evaluate response
to an infectious agent with a nonrespiratory predilection. Litters consisting
of 10 CD-1 pups were given 0.10 ml MHV 3 intraperitoneally; dilutions were
10-1, 10-2, or undilute (1 litter per dilution). The litters were maintained
in individual nest boxes and placed in the hypobaric chamber. Ambient
pressure controls were treated the same, and maintained in the same room
(not in isolators). Mortality was closely observed, and recorded 4 timis/day
for both chamber and control groups. The experiment was. terminated and the
chamber returned to ambient pressure 2 days after the last chamber test
subject succumbed to the infection.
4. INFLUENZA A/PR-8 INFECTION IN SCE
These tests were performed to establish whether viruses affecting
the respiratory system are enhanced under hypobaric, normoxic chamber
conditions. In the first experiment, 3-week-old CD-1 mice were anesthetized
with pentabarbital and given 0.50 ml A/PR-8, intranasally. The following
levels of virus were instilled: 10-1, 10-2, 10-3 , 10-4 , and 10-5 (6 mice
used per dilution). Once the animals recovered from the pentabarbital,
they were brought to 5 psi (34% atm.) at the ascent rate of 1000 ft/min.
Ambient pressure controls were identically treated and maintained in standard
nest boxes in the same room. Mortality was recorded as in the MHV experiment
described above, and, as in that experiment, the chamber was returned to
ambient pressure 2 days after the last chamber subject died.
This experiment was repeated, but a few changes in animal mainten-
ance were made. Moist food was used to avoid humidity problems associated
with water bottles; also the chamber temperature was increased from the 18-
200 C range to 20-220C range. Further, since a very high mortality was
observed in the first A/PR-8 experiment, a slightly smaller dosage of virus
was given. Two additional control groups were included to allay fears that
spontaneous pneumonia resulted in the high mortality of the first experiment.
Six untreated mice were placed in chamber A; six other mice were anesthetized
and given isosaline intranasally, and they, too, were then placed in Chamber
A. Test subjects instilled with influenza A/PR-8 were housed in Chamber B,
with air flowing from Chamber A to Chamber B to minimize airborne spread of
the agent (inner doors of the lock were slightly opened, and the entire
chamber was operated as 1 large cabin). Control animals were identically
treated and housed in the same room using similar maintenance practices.
the first experiment. Six untreated mice were placed in chamber A; six
other mice were anesthetized and given isosaline intranasally, and they,
too, were then placed in chamber A. Test subjects instilled with influenza
A/PR-8 were housed in Chamber B, with air flowing from Chamber A to Chamber
B to minimize airborne spread of the agent (inner doors of the lock were
slightly opened, and the entire chamber was operated as 1 large cabin).
Control animals were identically treated and housed in the same room using
similar maintenance practices.
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D. RESULTS
1. HYPOBARIC EFFECT ON MICE
As mentioned earlier, due to failure of the vacuum system, the 28-day
mission was aborted on day 4, after approximately 104 hours of operation. The
initial experimental design was continued as planned, because it was felt that
the initial ascent was the stressful period, and also, that descent was probably
stressful regardless of the length of the hypobaric, normoxic treatment.
Organ weight assays reflected some differences ;between chamber animals
and controls (Groups I and III, respectively). It is important to notice that
both spleen and thymus weights were affected by descent on day 4, but the stress
effect was more pronounced on the thymus (Figs.18 and 19). On day 7, 3 days
after descent, the thymus weight of controls was 0.50% of body weight, while on
the other hand the chamber animals had average thymus weights that were only
0.22% of body weight. Prednisolone treatment depressed lymphoid organ weights --
spleen, liver, (Fig. 20), and thymus weights of this group were notably smaller
than all other groups. Body weight was also lower in the Prednisolone-treated
group (Fig. 21). As anticipated, kidney weights did not establish any trend
(Fig. 22).
The combined effect of Ti0 2 aerosolization and exposure to SCE (Group
IV) resulted in lower spleen and thymus weights on most kill days, as compared
to their controls (Figs. 18 and 19, lower graphs). Aerosolized TiO 2 was cleared
at similar rates from chamber and control animals (Fig. 23).
2. HYPOBARIC EFFECT ON FERRETS
The ascent to altitude did not outwardly harm the test subjects--no
signs of bends or other discomfort was noticed in the hypobaric groups. All 5
experimental groups gained weight (Fig. 24) during the test run, as expected of
young animals.
Figure 18. Hypobaric Effect on Mice;
Thymus Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: TiO 2 - Chamber
Group V: TiO2 control
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Figure 19. Hypobaric Effect on Mice;
Spleen Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti0O2 - Chamber
Group V: TiO 2 control
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Figure 20. Hypobaric Effect on Mice;
Liver Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti02 - Chamber
Group V: Ti02 control
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Figure 21. Hypobaric Effect on
Body Weight in Mice
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti0O2 - Chamber
Group V: TiO2 control
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Figure 22. Hypobaric Effect on Mice;
Kidney Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: TiO 2 - Chamber
Group V: Ti02 control
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Figure 23. Hypobaric Effect on Mice;
TiO2 Clearance
Figure 23
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Figure 24. Hypobaric Effect on
Body Weights in Ferrets
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti0 2 - Chamber
Group V: Ti0 2 control
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FERRET: BODY WEIGHT
Prednisolon
800 0
0-
Control Chomber
600 
-
o \
400-
I 3 7 12 21 28
900DAYS
0 900
Ti02 Control
700
A TiO Chambe.r
500 ! I 1 I I
I 3 7 12 21
DAYS
,7.
Organ weight assay trends (Figs. 24-28) were similar to the pilot
experiment in mice described above. Corticosteroid hormone treatment depressed
both spleen and thymus weights, and to a lesser extent liver and kidney weights.
For example, spleen weights of the Prednisolone-treated animals stabilized
through the course of the experiments at 0.40% of body weight, while the control
spleen weight value was 0.70% of body weight.
The effect of hypobarism on spleen weight resulted in reduced spleen
size, from a value of 1.3% (of body weight) on day 0 to 0.81% on day 3;,,control
animals showed a similar reduction in spleen weight values, decreasing from 1.3%
on day 0 to 0.78% on day 3. Actual spleen weights on day 0 ranged from 5.2 g to
11.6 g, averaging 7.8 g, larger spleens than found in unstimulated ferrets.
Thymus weights of ferrets were not greatly affected by hypobaric
treatment, unlike mice, which had severely depressed thymus weights on day 7.
In the ferret, the ambient pressure controls (Group III) had slightly smaller
thymus weights on days 12, 21, and 28 than the hypobaric test group (Group I),
but these differences are probably not significant.
Hypobaric test subjects cleared Ti0 2 at the same rate as the ambient
controls (Fig. 29); these results indicate that respiratory cellular functioning
was not malaffected by SCE exposure. However, TiO 2 aerosolized animals which
were subjected to SCE had lower body, spleen, thymus, and liver weights on the
majority of the kill periods, compared to the aerosolized controls (Group V).
Relative to the other three groups, both aerosolized groups (Groups IV and V)
had organ and body weight values within the normal range.
Humoral antibody production to Brucella abortus was used as an indicator
immune system functioning in the SCE. Standard tube agglutination tests revealed
a decrease in overall titer (Fig. 30) which suggests that the later stage of
antibody synthesis, responsible, for IgG production, was suppressed. This
Figure 25. Hypobaric Effect on Ferrets;
Spleen Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti0 2 - Chamber
Group V: Ti02 control
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Figure 26. Hypobaric Effect on Ferrets;
Thymus Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: TiO2 - Chamber
Group V: TiO2 controls
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Figure 27. Hypobaric Effect on Ferrets;
Liver Weight Assay
Group I: Chamber
Group II: Prednisolone
Group III: Chamber control
Group IV: Ti0O2 - Chamber
Group V: TiO 2 controls
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Figure 28. Hypobaric Effect on Ferrets; Kidney
Weight Assay (Left and Right Kidneys
Together as Percent Body Weight)
Group I: Chamber
Group II: Prednisolone
Group III: Chamber controls
Group IV: TiO2 - Chamber
Group V: Ti02 controls
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Figure 29. Hypobaric Effect on Ferrets;
TiO2 Clearance.
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Figure 30. Hypobaric Effect on Ferrets; Brucella
antibody titers determined by tube
agglutination assay
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cessation of antibody production was also noticed in the ambient controls, which
were housed in isolators. In order to establish a typical antibody pattern for
ferrets housed in a nonrestrictive environment, a group of immunized animals
were maintained in standard wire cages at ambient pressure (Fig. 30, "Room
Control"). One sees that these ferrets exhibited the expected rise in antibody
titer, as defined by standard tube agglutination tests.
To determine whether IgG synthesis was actually depressed in chamber
animals, the sera were treated with mercaptoethanol. Subsequent readings of the
tubes showed that IgG production was severely depressed in the chamber:group,
which exhibited no detectable titer on days 12 and 28, and a titer of 6 (reciprocal
of dilution) on day 21. Ambient control animals also showed a decrease in IgG
synthesis, but titers were appreciably higher throughout the experiment; for
example, on days 12 and 28, this group had titers of 16, and on day 21, a titer
of 64 (Fig. 31).
3. MURINE HEPATITIS INFECTION IN SCE
As it was previously thought that respirtator infections are enhanced
by exposure to SCE, an experiment was included to evaluate response of an infectious
agent with a nonrespiratory predilection, such as mouse hepatitis virus. Experi-
mental data show that chamber subjects began to die one day earlier than ambient
dome controls, but the overall mortality patterns were similar (Fig. 32).
4. INFLUENZA VIRUS INFECTION IN SCE
In the first pilot experiment performed, mice in both hypobaric and
ambient groups began to die 3 days after instillation with virus. However, the
death rate of the hypobaric subjects was much more severe than in the controls,
and by day 4, more than 50% of the hypobaric subjects, but only 6.6% of the
controls, had died. At the termination of the experiment on day 11 (2 days
after the last chamber subject had died), 90% of the hypobaric group, but only
Figure 31. Hypobaric Effect on Ferrets; Brucella
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Figure 32. Response of Mice Housed in SCE
to MHV Infection (Mortality is
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43.3% of the ambient controls, had died (Fig. 33). (Values given are the average
cumulative mortality of the 5 dilutions tested.)
Due to the severity of illness incurred during the first experiment,
when it was repeated, a slightly smaller dosage of virus was given, and the
chamber temperature was increased to provide a more suitable mouse*environment
(20-240C). Moisture-rich sterile food was used, which eliminated the problem of
leaky valves in water bottles. With these modifications, the experiment was
continued as before. Animals from both hypobaric and ambient pressure control
groups started to die on day 4, at which time the experimental results were
similar to the first experiment, i.e., initially the morality was more severe in
the hypobaric animals (Fig. 34). Specifically, on day 7, approximately 23% of
the chamber animals, but only 10% of the controls, had died.
Figure 33. Response of Mice Housed in SCE to
Influenza A/PR-8 Infection (Trial i).
(Percent Mortality is Cumulative.)
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Figure 34. Response of Mice Housed in SCE to
Influenza A/PR-8 Infection (Trial 2)
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E. DISCUSSION
Increased susceptibility to infectious diseases as the result of
factors associated with spacecraft environments has not been clearly established.
However, the frequency of "minor colds" experienced by astronauts in flight, and
the experimental evidence for altered susceptibility (Aerospace Med. 38:382,
1967; 40:176, 1969) prompts consideration of depressed physiologic and immunologic
responses as a result of environment stress. Depression of normal immune mechanisms
at the lymphoid level by pituitary-adrenal homones has been well established
(Immunology 15:643, 1968; J. Immunol. 98:1076, 1967) andjassociated with the
central role of these hormones in physiologic stress (The Physiology and Pathology
of Exposure to Stress, Selye, H., 1956, ACTA, Inc., Montreal).
Another factor of near equal importance in induction of respiratory
disease is the function of the mucociliary system (Health Physics 2:379, 1960).
Studies of pulmonary clearance (J. Clin. Invest. 43:4, 1964) indicate a two-
phase response involving a rapid phase and a slow phase following exposure to
environmental pollutants; i.e., microbiologic aerosols, tobacco smoke or radioactive
aerosols. The rapid phase is primarily associated with the cephalad movement of
the mucous blanket while the slow phase involves alveolar clearance via the
reticuloendothelial and lymphatic transport system. Thus, it is clear that
factors which alter the "viscidity" of "excessive fluidity" impair the non-
Newtonian mucosal movement of inhaled particles by the ciliated cells.
In general, particles considered as being "lung damaging" in size
range from 0.25 to 10 v. Particles of less than 0.25 V are seldom retained in
the lungs and particles with diameters greater than 10 p are lodged in the
mucociliary systems of the upper respiratory tract and hence do not reach the
bronchi (Pulmonary Deposition oflnhaled Aerosols, Hatch, T. and Gross, P., 1964,
Academic Press, New York). At sea-level the majority of "free-formed" aerosolized
virus particles are of a size range which would not be retained in the lungs.
However, this is not true at reduced atmospheric pressures. The difference in
aerodynamic equivalent diameters of a given particle at New York as opposed to
Denver is 20% larger (Raabe, 0. G., In: Inhalation Carcinogenesis (M. G. Hanna,
Jr., P. Nettesheim and J. R. Gilbert, editors), U. S. Atomic Energy Commission,
Oak Ridge, Tennessee, 1970). This coupled with aerosol aging (aggregation)
which would still occur at zero gravity in actual space flight alters the pathogenic
character of biologic aerosols.
Utilizing the low-pressure facility designed to house mice and ferrets
for periods up to 180 days, the environmental conditions proposed for the Skylab
mission, namely, a gas mixture of 70:30 02 :N2 and an atmospheric pressure
of 5 psi (34% atm.), were tested. The SCE tested in this study has a partial pressure
of 02 equivalent to that normally found at sea level, and thus is hypobaric,
normoxic. During chamber tests, overall health of experimental animals was
evaluated by clinical appearance of test subjects. In the first 2 hypobaric
tests, in which young mice and ferrets were used, and even when suckling mice
were used as in the MHV experiment, no signs of bends or other discomfort were
noted upon ascent or descent in altitude. Organ (lymphoid) weight assays were
used as indicators of stress. The SCE effect on alveolar macrophages was evaluated
by following clearance rates of TiO 2 in animals which had been aerosolized prior
to SCE exposure. Activity of the immune system was investigated by quantitation
of humoral antibody to Brucella, and then IgG activity was separated from IgM
activity by mercaptoethanol inactivation of IgM. Finally, response to viral
disease - influenza and hepatitis - was evaluated to confirm or deny reports
that SCE is particularly enhancing to those viruses having a respiratory
predilection.
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In both the mouse pilot experiment, and the study using ferrets,
spleen and thymus weights of chamber animals were reduced.i Control ferrets,
which were housed in isolators, also had reduced spleen and thymus weights,
apparently due to confinement stress. In the ferret, the spleen was more affected
by SCE and isolator confinement, whereas in the mouse, the thymus was the target
organ. Both mice and ferrets exposed to SCE also exhibited slightly reduced
kidney and liver weights throughout the experiment. The data suggests that
there is a stressful period at the time of ascent or descent in altitude, and
that the effect may vary according to the species. The stress of confinement
and hypobarism probably stimulates corticosteroid hormone production, which may
have alternate effects on mice and ferrets; the effect of corticosteroids would
account for reduced spleen weights in ferrets, and reduced thymus weights in
mice.
A Prednisolone-treated group was included in both mouse and ferret
experiments in order to establish a maximum stress effect of the hormone on
lymphoid and other organs. The reasoning was that if the effect was not de-
tectable after a relatively high dosage of corticosteroids were administered,
then stress due to factors associated with SCE in the chamber which resulted in
corticosteroid release, could probably not be detected. In mice, Prednisolone
caused a marked depression in lymphoid organ size: spleen, liver, and thymus
weights were lower in this group than in any other. Ferrets also showed depressed
spleen and thymus weights after Prednisolone treatment; to a lesser extent,
liver and kidney weights were reduced. (By 21 and 28 days, the Prednisolone
group caught up with the controls.) At the level of hormone given a species
distinction, regarding the mode of action of the drug, was not observed - virtually
all organ and body weights of mice and ferrets were lower in this group than in
the other 4 groups. The depression in lymphoid organ weights suggests that the
drug.affects transformation of stem cells along the plasma line, and thus a
reduced population of these cells was detected in lymphoid organs.
Earlier NASA programs had developed methodology and established baseline
parameters for lung clearance of inert dust, specifically, TiO 2 (Contract No.
NAS 9-11575, Biological Activity of Lunar Soil). These preliminary experiments
had shown that aerosolized Ti0 2 was in the submicron range, and therefore is
deposited mainly in the acini of the lung; particle measurement was accomplished
by light microscopy, sedimentation analysis, and most recently, by Scanning
Electron Microscopy (Fig. 35). Ti0 2 clearance was used as a model to determine
whether environmental conditions in the chamber, such as gas mixutre, humidity,
temperature, and ammonia fumes, would alter the alveolar clearance rate. Mice
and ferrets exposed to SCE after 24 hours of aerosolization, cleared TiO 2 at
approximately the same rate as their ambient controls, suggesting that the SCE
was not detrimental to alveolar phagocytosis. The slope of the clearance curves
imply a rapid clearance of Ti02; however, the data is somewhat misleading. Due
to increase in body weight and, therefore, lung weight, concentration of Ti02
per gram of wet tissue would naturally show a decreasing trend. An earlier
study with mature ferrets had shown that over 90% of deposited TiO 2 remained
after 30 days.
During both mouse and ferret experiments, the ambient controls were
held in rigid plastic isolators, in order to maintain similar air flow and
temperature to the chamber. An earlier study (Coyne, R. V. and Ackerman, G. A.,
Aerospace Med. 40:1219-1223, 1969) has reported that spleen weights and serum
antibody titers to Brucella abortus were decreased in animals subjected to 100%
02 at 5 psi, as did mice held in ambient pressure domes. Perhaps the comparison
between chamber subjects and controls would have been more meaningful if the
controls were held in conventional cages, which was done in the influenza virus
and hepatitis virus experiments.
Figure 35. Scanning Electronmicrograph of Ti02
Figure 35
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Ferrets immunized with Brucella abortus 5 days prior to SCE
exposure, as well as their controls, revealed a decrease in antibody titer
during the 28-day test. Such a decrease in antibody titer suggests that
the later stage of antibody production which synthesizes IgG, was suppressed.
Animals given an identical inoculation, but housed in standard wire cages,
exhibited an increase in titer, as expected after a primary immunization.
To separate IgM antibody activity from IgG, both of which are detectable by
standard tube agglutination tests, sera from chamber animals and theirl t
controls (housed in ambient pressure domes) were incubated with mercapto-
ethanol. Mercaptoethanol reduces the disulfide bonds which covalently-
binds holds together the IgM polymers, thus inactivating it. Immunoglobulin
in IgM, which is synthesized primarily during the early stage of the immune
response, is mercaptoethanol sensitive, while IgG under these conditions,
is not. When the sera were so treated, the total serum titers decreased,
most notably in the chamber group; the decreasing trend suggests that the
initial antibody produced was catabolized, and that synthesis of IgG was
either depressed or inhibited. The IgG levels for both groups were much
lower than the combined IgG and IgM titers, was expected.
Response to viral infection in the simulated spacecabin was
performed because IgG synthesis appeared to be suppressed, and also to
establish whether the SCE enhanced only respiratory infections, as had been
intimated in the literature. Bacterial and viral infections have been
reported either enhanced or unaffected by various spacecabin conditions.
J. P. Schmidt (Fed. Proc. 28:1099-1103, 1969), for example, had observed
heightened infection with mengovirus, but not influenza virus, when conditions
were hypobaric and normoxic at the time of infection. These results also
support the belief that the stressful period is at the time of change in
barometric pressure. (For correlation of studies see altitude conversion
graph on Figure 36.)
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Since it seemed probable that the effect of SCE ,depended on the
response evoked by the agent, a virus having a predilection for the respira-
tory system, mouse-adapted influenza, was chosen, and for comparison,.
murine hepatitis virus was also studied. The course of influenza virus
infection was much more severe in the chamber animals. A preliminary
experiment showed that the chamber animals had nearly twice the mortality
of the controls; when repeated the mortality rate of the chamber animals
was enhanced, suggesting a trend of shortened time of disease onset, but
the cumulative mortality at the end of the experiment was similar in both
groups. The possibility of spontaneous pneumonia being the primary cause
of deaths was discounted; uninoculated controls maintained in the chamber
did not die or appear ill. When hepatitis virus was given, however, the
difference in mortality between chamber and control subjects was negligible.
Enhanced influenza infection, but not hepatitis, can be explained
since murine hepatitis virus is known to elicit humoral antibody production.
This virus replicates in the liver Kupffer cells, which process the antigen
and start the sequence of events resulting in lymphocyte transformation
into the plasma cell series. It is not yet clear how influenza virus is
processed, but it is thought to evoke a T-cell or combined T- and B-cell
response. In mice, the thymus size was decreased by SCE exposure, while
the spleen remained similar in size to controls. One can postulate that
murine hepatitis virus infection was not enhanced due to normal activity of
the humoral immunity system, as suggested by normal spleen weights. However,
a defect in the T-cell system would impair response to an antigen which
probably involves action of both T- and B-cells. In the ferret there is
evidence that B-cell function was impaired as a result of SCE exposure
because 1) spleen weights decreased and 2) IgG synthesis was suppressed.
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VII. ANTIBODY AFFINITY AS A FACTOR IN CHRONICITY OF VIRAL DISEASES
(CONTRACT SUPPLEMENT, NAS 9-11941, MOD. No. 4S).
A. SUMMARY OF WORK COVERED BY MOD No. 4S.
1. Studies on development of the methodology for preparation
and use of immunoadsorbents may be summarized as follows:
a) No advantage was obtained in using immobile supporting
material with aliphatic side arms such as Affi-Gel 10, which is an agarose
bead with a 10 angstrom aliphatic side arm terminating in a carboxy N-
hydroxy-succinimide ester, over procedures using covalent binding of antibody
directly to the polyhydric backbone of Sepharose 4B through the cyanogen
bromide reaction.
b) A salt gradient ranging from 0.05 to 3.0 M NaCl displaced
virus from immunoadsorbents prepared with rat anti-EMC and mink anti-ADV
but not from mink anti-EMC.
c) Acid gradients ranging from pH 7 to pH 2 (glycine-HC1 in
1.,0 M NaCl) dissociated virus at pH 5.0 from immunoadsorbents prepared with
mink anti-ADV and not others.
d) However, in all cases when the pH of the immunoadsorbent
column was returned to near neutrality, virus was dissociated from all
columns tested, mink anti-ADV, mink anti-EMC and rat anti-EMC.
2. Virus characterization based on studies with immunoadsorbents.
Studies on the characterization of the ADV may be summarized
as follows:
a) Measurements from electron micrographs indicate ADV to
be 25 nm in diameter and appear as an icosahedral particle (see Fig. 37
below).
Figure 37
Shown above are ADV particles from a mink kidney cell culture.
The intact particles on the left have a buoyant density of 1.34
and the empty particles on the right, 1.29 in cesium chloride
gradient. If this virus is classified as a picornavirus (based
on 3H-uridine uptake; capsid polypeptide pattern resembling
other picornavirus; apparent cytoplasmic replication as indicated
by Tsai and co-workers), the presence of empties in cell culture
would further suggest that it belongs to the enterovirus subgroup.
Figure 38
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Depicted (top) is typical periarteritis nodosa with medial
necrosis in ADV infected mink. In a survey of 100 commer-
cially raised mink possessing gammapathies, 17% had severe
vascular lesions. Bottom photograph depicts arteritis
(cerebellum) in ADV infected ferret. Aleutian disease in
ferrets results in a higher incidence of monoclonal typegammapathies under ranch conditions.
& -A,
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b) The virus has been shown to incorporate isotopically-
labeled uridine and not thymidine.
c) When analyses were conducted on mink kidney cell cultures,
both empty and full particles were obtainable in separate fractions; intact
particles have a density of 1.34 and empty particles, 1.29 (cesium chloride
gradients).
d) Characterization of the peptides by SDS-gel electrophoresis
has revealed 5 polypeptide components.
e) When purified virus is inoculated intq mink, typical AD
develops.
f) In L-cell cultures, CPE (as cell death) resulted 5 days
after inoculation.
g) In mink kidney cell cultures, similar changes occur in
established monolayers of cells.
h) Using capsid labeled (3H mixed amino acids) intact and
empty particles, empty particles bind to affinity columns at 91% level as
opposed to 52% level for intact particles.
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B. DETAILED REPORT OF WORK COVERED BY THIS PERIOD:
1. Aleutian disease as a model for studies on antibody affinity
and chronicity patterns of virus diseases.
Aleutian disease (AD) of mink is caused by a virus possessing
picornaviral characteristics and is manifested as a systemic proliferation
of lymphocytes/plasmacytes with concomitant hypergammaglobulinemia, segmental
vasculitis and fibrinoid deposition in the arterial walls and renal glomeruli.
Since Helmboldt and Jungherr first described AD (Am. J. Vet. Res. 19, 212,
1958), considerable attention has been given to the develppment of vasculitis
ranging from observations of isolated field cases to studies on the sequential
development of lesions in infected ranch mink (Henson et al., Pathol. Vet
3, 289, 1966). However, this and other studies lacked definitive precision
since the actual time course was not established in experimental studies,
and the inocula used~were crude tissue extracts from chronically infected
mink (Henson et al., Lab. Invest. 19, 153, 1968). The virus may have
existed in complex or aggregate form when inoculated.
As shown below, in mink and ferrets (Fig. 38) with Aleutian
disease (Kenyon et al., Am. J. Vet. Res. 28, 1167, 1967), vasculitis becomes
a striking feature in mustelids during chronic stages of the disease. In
both mink and ferrets this may be associated with a transition from hetero-
genous IgG gammopathy (polyclonal) to a highly homgeneous IgG (monoclonal).
It has not been established whether the vascular lesions in mink and ferrets
are a time dependent phenomena unrelated to specific features of the immuno-
globulin elicited in response to the virus or are aofunction of antibody
affinity/avidity.
In diseases such as AD, where viral chronicity is a prominent
characteristic, an ideal situation exists for studies on the development of
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immune complex disease and vasculitis. First, the virus is antigenic,
and it may be replicating in endothelial cells of infected mink (Tsai et
al., Can. J. Microbiol. 15, 135, 1969). This consideration is based on the
description cytoplasmic crystalline arrays of particles in vascular tissue
from AD infected mink. Porter and co-workers found AD antigenic material
in phagocytes (Von Kupffer cells) during the first 10 days postinoculation
with direct immunofluorescence using immunoglobulin from chronically infected
mink (Porter et al., J. Exp. Med. 130, 575, 1969). However, the presence
of virus in these cells may have been primarily the function hepatic immune
clearance. Secondly, in AD as in other viral infections, the agent is
self-replicating, thus producing a continuous supply of antigen. Third,
the immune response results in nonneutralized complexes which retain their
ability to infect and perpetuate the infection (Porter and Larsen, Proc.
Soc. Exp. Biol. Med. 126, 680, 1967). These points were brought out by
Notkins in a study of infectious virus-antibody complexes in which he
suggests that virus-antibody complexes like other antigen-antibody complexes
activate biological mediators which result in immunopathologic changes,
such as increased capillary permeability and migration of polymorphonuclear
leukocytes (Notkins, J. Exp. Med. 134, 41, 1971).
It is important to note that in AD antibodies of greatly different
affinities have been described (Fig. 39-41 below) and that the role of low
affinity or low avidity antibody has not been experimentally studied in the
development of vasculitis and glomerulonephritis. In mink as well as other
species, the usual response to immunizing agents is a neutralizing antibody
of high affinity and with apparently increased avidity upon repeated immuni-
zation. This has been shown with mink immunized with the encephalomyo-
carditis virus (EMC).
Figure 39
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Depicted in this graph is the elution profile of capsid-labeled
ADV from an immunoadsorbent column prepared with a mixture of
monoclonal and polyclonal immunoglobulins from ADV infected mink.
The column bed volume was 5 ml and was prepared with Affi-gel 10
adsorbent. A total of 20,000 cpm as 3H-capsid-labeled virus were
applied to the column; elution consisted of NaCl gradient (0.1 -
3.0 M at pH 7.6). The first large peak consists of the percolate
containing unbound virus, the second peak represents the virus
displaced at 0.5 M NaC1.
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Depicted in this graph is the elution profile of encephalomyo-
carditis virus (EMC) with 3H-labeled capsid displaced from an
immunoadsorbent column prepared with rat anti-EMC IgG. The
conditions for column preparation and chromatography were like
that shown in Figure 2. As in Figure 2 with mink anti-ADV system,
labeled material was desorbed from the immunoadsorbent at 0.5 M
NaCl. In a similar experiment using mink anti-EMC as the
immunoadsorbent, no components were detectable in the salt
eluate. In these experiments it became apparent that mink
develop a high titer-high affinity antibody when injected intra-
cranially with EMC (104 mouse LD50 ).
Figure 41
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Shown above are graphs of acid eluates from immunoadsorbent
columns subjected to salt gradients (Figs. 2 and 3). The
broken lines represent the pH gradient established and glycine-
HCl (0.2 M) in 1.0 M NaCl. The heavy solid line is the elution
profile for EMC fractions and the lighter line represents frac-
tions from ADV system. Two observations are apparent in this
figure: a) only with ADV were components obtainable at approxi-
mately pH 5.0 and b) in all cases, when the pH was restored to
neutrality, addition virus was desorbed. In the case of EMC,
these fractions desorbed by neutralization were infections. In
the system using mink anti-EMC immunoadsorbent, no virus was
eluted until the column was restored to neutrality.
Figure 42
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Depicted above are graphs of labeled virus in percolates showing
the relative binding affinities of polyclonal (broken line) and
monoclonal (solid line) anti-ADV IgG immunoglobulins in varying
concentrations of NaCl. Immunoadsorbent columns were prepared by
binding each kind of IgG to Sepharose 4B with cyanogen bromide.
(Monoclonal IgG was isolated from pooled sera having gamma globu-
lins with electrophoretic homogeneity equal to that of serum
albumin on cellulose acetate membranes; IgG was classed as poly-
clonal when the heterogeneity was 3 times as broad as serum
albumin.) Columns (1.5 ml of immunoadsorbent) were used for each
salt concentration and equilibrated against that salt solution
before ADV (3H-capsid-labeled, 1400 cpm in 20 pl) was added to
each of the 2 types of immunoadsorbent. The concentration of
label in the percolates is inversely proportional to the binding
power of each kind of immunoglobulin at a given salt concentration.
The data suggests that polyclonal immunoglobulins are suppressed
by salt concentrations above and below the physiologic range.
2. Virus isolation and characterization.
Since the first description of AD by Helmboldt and Jungherr, the
virus has remained unclassified and the various strains used in research
uncharacterized. The virus that this investigator passaged since 1961 has
a target-size molecular weight of 1.5 x 106 (estimated from inactivation by
ionizing irradiation) and produced typical infiltrated of lymphocytes and
plasmacytes in many organs with a doubling of serum gamma globulin concen-
tration by 30 days after inoculation.
The approach which proved successful in isolatipn of the virus
from mink tissue extracts (Kenyon et al., Science 179, 187, 1973) and :
later, by this laboratory, from L-cell cultures (Yoon et al., Nature 245,
205, 1973) and from mink kidney cells (Yoon et al., Fed. Proc. (Abst. 2227)
605, 1974) was affinity chromatography. Briefly, the use of an immuno-
adsorbent for ADV isolation consisted of covalent binding IgG anti-ADV with
cyanogen bromide to Sepharose 4B (other solid phase covalent linked systems
have been used; see below). Virus containing extracts from in vivo or in
vitro systems were percolated through the immunoadsorbent (viral sorption)
followed by washing of the immunoadsorbent until the effluent buffer is
identical before and after in radioactivity or detectable chemical composition.
Elution (desorption) systems used consisted of salt gradients and pH gradients
superimposed on 0.75 - 1.0 M NaCl with glycine-HCl buffers ranging from pH
7.0 to 2.0. Eluate fractions are collected until the immunoadsorbent is
returned to neutrality. This procedure has been widely used to isolate
dilute antigens, enzymes, haptens and ligands (as reviewed by Cuatrecasas,
Adv. Enzymol. 36, ed. Merster, J., Wiley and Sons, New York., 1972).
However, viruses have not been isolated by this technique, presumably
because of the difficulty in obtaining sufficient quantities of specific
.128.
antibody and lack of development of conditions which allow.desorption of
intact virus. Aleutian disease virus seemed suitable for isolation by
immunoadsorbents since large amounts of presumably specific antibody are
produced during the disease (Porter et al., J. Exp. Med. 130, 575, 1969)
(see Fig. 37).
Other applications of affinity chromatography in isolation of
animal viruses (by this laboratory) concerned refinement of procedures,
using IgG immunoglobulins produced in rats and mink by immunization with
EMC since this virus has been extremely well characterized (Reuckert,
Picornaviral Architecture, Comp. Virol. Ch. 8, Academic Press, N. Y.,
1971), and it has a relatively simple capsid configuration, 3 major peptides
and 1 minor. The fact that the virus is similar to ADV and can be easily
quantitated by hemagglutination, plaque assay, bioassay in mice and elicits
high antibody titers in mink as well as rats, it was selected for comparative
analyses and development of standard procedures.
Since in AD a tremendous gammapathy exists, there is little
likelihood of an antigen excess occurring in the peripheral circulation.
Thus, another mechanism such as low affinity/avidity antibody may be respon-
sible for lack of immune complex clearance. Recent studies on antibody
affinities directed towards viral determinants (Kenyon et al., Fed. Proc.
p. 605 (Abst. 2228), 1974) has shown that at least several broad classes of
affinities exist. In these experiments it was shown that mink immunized
with EMC produced high titers of antibody with high affinity, i.e., labeled
virus (3H-amino acids) could not be eluted in salt gradients from 0.1 M to
3.0 M NaCl or with glycine-CH1 gradients (pH 7 to 2) in 1 M NaCl. On the
other hand, mink anti-ADV immunoadsorbent systems showed components in salt
eluates at 0.5 M NaCl and again at pH 5.0 on the acid gradients. Rats
immunized with EMC produced antisera with high neutralization titers;
however, when evaluated on immunoadsorption columns, a component was eluted
with 0.5 M NaCl but not in the acid gradient. Graphs of these data are
shown above. If one compares early and late (polyclonal and monoclonal)
anti-ADV for ability to adsorb virus on a series of immunoadsorbent columns
equilibrated in various salt concentrations (ranging from 0.05 M to 1.0 M
NaCl), it was apparent that polyclonal columns in salt extremes (hypo- and
hypertonic) did not adsorb virus as well as monoclonal columns (see Figu 42
below). In all experiments, when the columns were restored to neutrality,
labeled capsids/ virus appeared in the eluates. This material in experiments
with EMC was still infectious after desorption when assayed for infectivity
in CD-1 mice.
Experiments performed by Nicklin and Stephen (Immunochemistry 11,
35, 1974) on recovery of protein antigens from immunoadsorbent columns
prepared with non-avid antisera, indicated elution profiles similar to
those seen with AD, i.e., protein components eluted at pH ranges of 4 to 5.
They found that columns of non-avid sera adsorbed and released homologous
antigen 3-4 times more efficiently than columns prepared with the avid
counterparts (antisera). For virus isolation, in procedures where antigenic
structure is a function of the capsid configuration, it becomes important
to dissociate or desorb the virus under conditions which will not denature
it. Thus, the efficiency of the procedure may be greatly enhanced using.
the properties of a subpopulation of antibodies possessing a lesser binding
affinity/avidity for homologous antigen without preliminary removal of
antibodies of higher binding strength. When columns are recycled, this is
achieved at the expense of an initial loss of antigen in the first cycle.
The necessity of sharp gradient formation in securing effective desorption
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of protein antigens using pH gradients has been reported (Crook et al.,
Immunochemistry 9, 945, 1972) and has been observed by this laboratory with
ADV (Kenyon et al., Science 179, 187, 1973).
In AD it is unknown whether the antibody subpopulation which
binds virus with greater affinity/avidity represents neutralizing antibodies,
and the weak binding subpopulation represents that species which forms
infectious immune complexes. Withantibodies to enzymes, it has been shown
that as the affinity of the antibody increases so does the degree of enzyme
inactivation, supposedly induced by changes in steric configuration (Erickson,
Immunochemistry 11, 41, 1974). Similarly, it appears that as the affinity
of antiviral-antibody increases, so does the viral inactivation rate and
reduction in human complex formation as shown with mink anti-EMC and with
rat anti-EMC.
Another possible factor in AD contributing to the pool of immune
complexes is the formation of defective particles. In many virus infections
the number of defective particles outnumbers infectious particles by as
much as 100 to 1 (Notkins, J. Exp. Med. 134, 41, 1974).
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VIII. PASSIVE IMMUNE AGGREGATION (EXTENSION OF CONTRACT NAS 9-11941
MOD. No. 4S).
A. SUMMARY OF WORK COVERED BY EXTENSION:
Studies on passive immune aggregation using the MEMS with antibody
prepared in mink and rats to encephalomyocarditis virus.
1. Work performed at NASA using instrumentation fabricated by
Aerojet Medical and Biological Systems.
a) Rate of decay (spontaneous aggregation) of antibody
coated beads balanced against uncoated beads showed no consistent trend.
b) Reactions of 3 levels of IgG anti-EMC treated beads
(10 mg, 6 mg and 1 mg) in total volume of 10 GBS with 0.1 ml EMC titered
from 10-1 to 10-6 produced no consistent trends in readings. (Although
Dr. J. L. McQueen, contract monitor, felt the approach to selection of bead
concentration and other factors seem empirical, the conditions used were
thosei escribed by the manufacturers of the test bed system, NAS 9-11371.
c) Determination of decay rates of only virus added to
uncoated beads indicated no significant effect.
2. Work performed at Sloan-Kettering Institute using Beckman
Acta III.
a) The Acta III was set up with water in the reference
holder and various bead concentrations in the sample holder (quartz cuvettes)
with wavelength at 470 and slit width at 0.4 to provide a concentration
giving an optical density of 1.0.
b) Decay rate or settling was determined overtime. A
constant rate (linear OD function against time) was A 0.5 0.0./15 min.
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c) During the following experiments, no consistent trends
were obtained. The factors tested were:
i) Variations of antibody concentration 0.001 mg/lO ml
bead solution as described on p. 11, Final Report, Contract NAS 911371.
ii) Range of temperature for sensitizing beads 260 C,
370C, and 560C.
iii) Length of time of sensitizing beads 0.5, 1.0, 3.0
and 6.0 hr.
iiii) Time and temperature of holdingi sensitizing.beads
before reading.
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B. DETAILED REPORT
The procedure used for preparation of sensitized latex beads was
as initially recommended on page 11, Final Report, Contract NAS 9-11371,
Aerojet Medical and Biological Systems.
The stock suspension (10%) of beads was washed in distilled water
and resuspended in 10 volumes of glycine buffered saline, pH 9.0 (GBS) 0.1
M glycine in 0.05 M NaCl at pH 9.0. A volume of antibody in GBS equivalent
to the original volume of stock beads, ranging in concentration from 1.25
to 5.0 mg/ml of antibody protein depending on bead size.< The mixture was
agitated gently for 30 minutes at room temperature after which an equal
volume of GBS was added and the incubation was continued for an additional
30 minutes.
The supernatant was removed after centrifugation at 3000 x g for
5 minutes. The resultant beads were reconstituted to 25 times original
volume in GBS containing 0.2% crystalline bovine albumin.
The antisera used was prepared in either mink or rats to encephalomyo-
carditis virus (EMC). The mink were administered 1 injection intracranially
of 104 ID (mouse infectious doses) and at 3 weeks later, another injection
of 104 ID given intraperitoneally. The intracranial inoculation produced a
transient encephalopathy which lasted 7 days. At the conclusion of this
immunization, the neutralization titers in vivo exceeded 106 ID50 and HAI
titer of 11 doubling dilutions. Antisera was also raised in the rat by
similar immunization routine; in which case, the titer was not as high (105
ID50 in vivo).
The IgG immunoglobulin fraction was isolated by DEAE cellulose
chromatography and concentrated to 1-2 mg/ml in phosphate buffer pH 7.6.
The efficiency of these antisera were also determined in a series of
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immunoadsorbent experiments using Sepharose 4B or Affi-Gel 10. Prior to use of
aliquots of the immunoglobulin, it was stored at -700C. In each case, the
titer the potency and quality of the immunoglobulin preparation was excellent.
In each experiment, the linearity of "readout" was determined
over a range of bead concentrations, and found to be linear as seen in
Figure 43 (plot on semi-logarithmic paper) and Figure 44 on linear paper.
It must be stressed as seen in Figure 45, that all assays conducted
with latex beads to which the antibody was noncovalently 'bound, no consistent
or reproducible trend was observed between aggregation and virus dilution.
This was true over all parameters studied, i.e., effect of antibody concentra-
tion, effect of incubation temperature, effect of length of incubation,
effect of bead concentration and effect of diluent used for virus. It
appears that the antibody must be bound covalently to the supporting matrix.
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IX. SUMMARY
Repeatedly, it has been suggested that there was a stressful
event associated with ascent or descent in altitude (Schmidt, Fed. Proc.
28:1099, 1969). In this study and in those conducted by Erlich and Mieszkuc
(Dev. Ind. Microbiol. 5:207, 1964) using animal models, they did not establish
the nature of the enhancement of disease in experimental subjects under
SCE.
Thus, a series of experiments were conducted starting with prelim-
inary studies performed at the Illinois Institute of Technology, Research
Institute (IITRI) to determine initial tolerability of ferrets to gas
ratios of 30% nitrogen and 70% oxygen under 5 psia. Depression of immuno-
logic responses related to stress of the initial event (decompressing to 5
psia) were evident at 7 days after introduction into Skylab environment.
Recovery to normal response was apparent by 21 days exposure. This evidence
consisted of decreased lymphoid organ weight and reduced response to antigenic
stimulation. Also in preliminary experiments, it became apparent that
histologic changes in the mucociliary system of the upper respiratory tree
were attributable to high levels of ammonium arising from animal waste due
to low turnover rates of gas environment.
Thus having extended the work previously reported in the sense
that disease enchancement could be a factor of stress mediated through
immunodeficiency, a program was initiated with a better designed chamber
which would not compromise animal health by accumulation of animal waste.
For this purpose, a stainless steel low pressure facility was
designed which consisted of 2 subchambers, that permitted mutual isolation
of experimental groups and/or selective by removal of animals without
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return of the entire cabin to ambient pressure. Throughout experimental
tests, the chamber environment was stable, fluctuating only 4-6 mm Hg in
pressure and 1-30 C in temperature. Upon ascent to altitude, neither young
adult mice, ferrets, nor suckling mice indicated signs of bends.
Mice subjected to the 70:30 02 :N2 and 5 psi cabin environment,
had severely reduced thymic weights 3 days after exposure to cabin atmosphere.
In ferrets, spleen weights were most affected by ascent to altitude; thymus
weights remained relatively unchanged. The fact that control ferrets ,
housed in rigid Plexiglas isolators with absolute filters showed a similar
trend in splenic weights due to stress factors related to the enclosed
environment. Animals housed in the open did not show these changes.
It is important to note that ferrets housed in the chamber described
in the text of this report were free of lesions in the mucociliary system.
Although rodents have a less distinct goblet cell and mucociliary blanket,
no changes were observable in these animals that could be attributed to
accumulation of ammonium in the SCE.
Murine hepatitis virus (MHV3 ) infection in SCE did not appear to
be enhanced, whereas influenza virus infection was. Since humoral antibody
response is a major factor in MHV3, it may be a response of primarily B-
type lymphocytes. Mice which had reduced thymic weights and not reduced
splenic weights indicate a prerequisite for reduced resistance to influenza
virus, which apparently involves T-cell or combined T- and B-cell function
as opposed to MHV3 which is known to elicit humoral antibody. In mice, as
indicated by normal spleen weights and humoral response, this limb of the
immune system was unaffected by SCE.
Our studies have clearly demonstrated that ferrets immunized with
Brucella Strain 19 prior to being housed in SCE had decreased synthesis of
140.
IgG from IgM was accomplished by inactivation of IgM with mercaptoethanol.
Chamber stresses, therefore, affected humoral antibody activity in the
ferrets, as indicated by reduced spleen weights and decreased IgG synthesis.
Because of the possibility of latent infections being responsible
for stress induced upper respiratoryi dseases of astronauts, the role of
neutralizing antibody as a function of antibody affinity/avidity was investi-
gated. The model consisted of Aleutian disease virus (ADV) which infects
ferrets and mink resulting in nonneutralized immune complexes. These ,
studies demonstrated that early antibody to ADV had lower, affinity/avidity
than late antibody with respect to chronicity. These studies culminated in
a description of antibody affinity, first isolation of ADV and its cultiva-
tion in vitro.
With the prospective development of antiviral agents and the
possible viral etiology of cancer, there is an increasing need for the
rapid detection of viruses prior to overt disease. Present methods of
virus isolation and identification commonly involved the use of cell culture
systems in order to increase the virus population to readily detectable
levels or the formation of cytopathic changes in the cultured cells. A
minimum of 72 hours and a maximum of upwards to a month or more are necessary
to accomplish the isolation procedures.
However, the use of immunoadsorbents as applied above, this ADV
has greatly facilitated detection and isolation from cell culture systems.
The prime factor required is either incorporation of an isotopic label or
an assay for the agent in eluates during desorption. By other methods, the
identification of the particular virus in question may involve 2 to 24
hours for the more rapid tests such as complement fixation and hemagglutina-
tion inhibition to 2 - 7 days for neutralization tests.
Thus it had been proposed that an efficient and rapid method of
detection be available, one which could detect viruses in an astronaut
before the symptoms of the disease were evident and the afflicted person or
persons could be isolated. With this knowledge, of course, space flights
could be aborted or astronauts substituted.
The method proposed for viral detection utilized passive immune
aggregation (PIA) technique. When viruses and certain types of homologous
antibodies react, the viruses are agglutinated and this agglutination 4
detected by a number of means. In the PIA technique, recommended by the
contract monitor, latex spheres (beads), on the order of I to 2 pm in size
were coated with specific antibody. When they react with viruses, agglutina-
tion occurred. This agglutination was detected by absorbency of transmitted
light.
Bead agglutination tests are in common usage to detect antigen-
antibody reactions. In some the antigen is attached to the beads to detect
antibody and in others antibody is coated on the beads and will react
antigen. Such tests are available commercially to detect rheumatoid factor,
C-reactive protein, antinucleoprotein factors associated with systemic
lupus erythematosis, and fibrinogen levels among others. These tests the
patients specimen is reacted with the sensitized beads and macroscopic
agglutination usually indicates a positive test.
Since then, passive immune aggregation represented an approach
that may be used to detect subclinical viral infections in astronuats or
possibly even cancer patients, this procedure was studied as a means of
rapid detection of viruses in animal systems. Preliminary analyses have
indicated the procedure described in contract NAS 9-11371, Microbial Ecology
Measurement System, was unworkable due to dissociation of antibody from
insoluble supporting matrix. As in affinity chromatography (immunoadsorption)
the antibody must be covalently bound to the supporting material to prevent
new adsorption equilibria from being established when exposed to antigen.
